EXOZ

eXoZymes, Inc.

EXOZ.US exozymes.com + Research + Basket
CIK 0002010788
Employees 32
Phone 626 415 1488
Fiscal year end December
IPO Nov 13, 2024
Address 750 Royal Oaks Drive, Monrovia, CA, United States, 91016
4.00
+0.20 (+5.26%)
USD · NASDAQ
52-week range
3.24
18.40
Trading at 5% of the 52-week range
Market Cap
35.36M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.39
Div. Yield
N/A
% Institutions
1.26%
% Insiders
65.35%

1 Year

-69.3%

3 Year

-56.1%

10 Year

-56.1%
Description

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Actions

Add an action for EXOZ.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Michael Heltzen President & CEO 1981
Dr. Tyler Korman Ph.D. Co-Founder & Chief Scientific Officer 1979
Dr. Paul Opgenorth Ph.D. Co-Founder & Vice President of Development 1983
Mr. James U. Bowie Ph.D. Founder & Independent Director 1959
Mr. Fouad Nawaz Vice President of Finance 1986
Mr. Damien A. Perriman Chief Commercial Officer 1977
Mr. Lasse H. Gorlitz Vice President of Communications NA
Mr. Michael Burns Executive Vice President of Energy Transition NA
Ms. Amy Lunzer Chief of Staff NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 08, 2026 Tyler Paz Korman N/A Sale 750.00 $10.04 $7.53K SEC
Jul 02, 2025 Michael Heltzen N/A Purchase 1.04K $10.22 $10.63K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Capital Management, LLC 54.99K Jun 30, 2026 0.59% $0.00 147.79%
Davidson Kahn Capital Management, LLC 25.00K Jun 30, 2026 0.27% $0.09 0.00%
Geode Capital Management, LLC 23.41K Jun 30, 2026 0.25% $0.00 6.92%
BlackRock Inc 9.61K Jun 30, 2026 0.10% $0.00 41.39%
Vanguard Fiduciary Trust Co 9.43K Jun 30, 2026 0.10% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 1.25K Jun 30, 2026 0.01% $0.00 0.00%
Tower Research Capital LLC 349.00 Jun 30, 2026 0.00% $0.00 -73.50%
Mercer Global Advisors Inc. 250.00 Jun 30, 2026 0.00% $0.00 0.00%
UBS Group AG 203.00 Jun 30, 2026 0.00% $0.00 745.83%
Barclays PLC 75.00 Jun 30, 2026 0.00% $0.00 0.00%
Bank of America Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 86.39K 0.93% ▲ 0.00% Sep 30, 2026
2 Fidelity Extended Market Index 11.73K 0.13% ▼ 0.53% Aug 31, 2026
3 iShares Micro-Cap ETF 10.95K 0.12% ▼ 0.69% Sep 30, 2026
4 Fidelity Series Total Market Index 2.94K 0.03% ▲ 0.00% Aug 31, 2026
5 Fidelity Total Market Index 2.02K 0.02% ▲ 0.00% Aug 31, 2026
6 Fidelity Nasdaq Composite Index 2.00K 0.02% ▲ 0.00% Aug 31, 2026
7 1290 VT Micro Cap K 810.00 0.01% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $35.36M
EBITDA: $-10.26M
Book Value: $0.39
Earnings/Share: $-1.19
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -74.74%
ROE (TTM): -187.16%
Revenue (TTM): $-700.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $30.32M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 9.30M
Shares Float: 7.19M
% Insiders: 65.35%
% Institutions: 1.26%
Short % Float: 0.44%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-5.91M
R&D
adjust
$-3.71M
Other Operating Expense
adjust
$-95.99K
Operating Income
subtotal
$-9.72M
Other / Non-Operating Items
adjust
$557.74K
Net Income
subtotal
$-9.16M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EXOZ.US!